ARMC
American Research & Management Company Portfolio holdings
AUM
$362M
This Quarter Return
+3.11%
1 Year Return
-8.06%
3 Year Return
+35.07%
5 Year Return
+60.97%
10 Year Return
–
AUM
$292M
AUM Growth
+$292M
(+6.4%)
Cap. Flow
+$28.1M
Cap. Flow
% of AUM
9.62%
Top 10 Holdings %
Top 10 Hldgs %
37.34%
Holding
394
New
29
Increased
31
Reduced
85
Closed
29
Top Buys
| 1 |
Waters Corp
WAT
|
$6.41M |
| 2 |
Weyerhaeuser
WY
|
$4.84M |
| 3 |
WFC.PRJ.CL
Wells Fargo & Company
WFC.PRJ.CL
|
$2.8M |
| 4 |
KEY.PRH.CL
KeyCorp
KEY.PRH.CL
|
$1.15M |
| 5 |
SPDR ICE Preferred Securities ETF
PSK
|
$1.05M |
Top Sells
| 1 |
Gentex
GNTX
|
$1.31M |
| 2 |
iShares Biotechnology ETF
IBB
|
$961K |
| 3 |
SPDR S&P Biotech ETF
XBI
|
$949K |
| 4 |
Gilead Sciences
GILD
|
$902K |
| 5 |
SFE
Safeguard Scientifics, Inc.
SFE
|
$500K |
Sector Composition
| 1 | Technology | 23.85% |
| 2 | Healthcare | 13.08% |
| 3 | Consumer Staples | 11.79% |
| 4 | Financials | 10.53% |
| 5 | Energy | 8.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Fortune Brands Innovations
FBIN
$7.02B
| $1.18M | 0.4% | 21,974 -1,200 | -5% | -$64.2K |
|
52
Pfizer
PFE
$141B
| $1.15M | 0.39% | 35,401 +7,931 | +29% | +$258K |
|
53
Marriott International Class A Common Stock
MAR
$72.7B
| $1.06M | 0.36% | 12,865 -300 | -2% | -$24.8K |
|
|
54
SPDR ICE Preferred Securities ETF
PSK
$812M
| $1.05M | 0.36% | +25,025 | New | +$1.05M |
|
55
Occidental Petroleum
OXY
$46.9B
| $1.04M | 0.35% | 14,540 -500 | -3% | -$35.6K |
|
56
PayPal
PYPL
$67.1B
| $1.03M | 0.35% | 26,080 +13,600 | +109% | +$537K |
|
57
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$3.7B
| $1.02M | 0.35% | 57,700 +13,750 | +31% | +$242K |
|
58
Bank of New York Mellon
BK
$74.5B
| $927K | 0.32% | 19,556 | – | – |
|
59
Alphabet (Google) Class C
GOOG
$2.58T
| $920K | 0.32% | 1,181 +87 | +8% | +$67.8K |
|
|
BPFHP
60
DELISTED
Boston Private Financial Holdings, Inc.
BPFHP
| $910K | 0.31% | 36,268 +3,050 | +9% | +$76.5K |
|
|
61
Gentex
GNTX
$6.15B
| $849K | 0.29% | 43,100 -66,575 | -61% | -$1.31M |
|
|
MMP
62
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $823K | 0.28% | 10,888 | – | – |
|
63
Helmerich & Payne
HP
$2.08B
| $798K | 0.27% | 10,315 | – | – |
|
64
Amgen
AMGN
$155B
| $777K | 0.27% | 5,314 -250 | -4% | -$36.6K |
|
65
Novo Nordisk
NVO
$251B
| $762K | 0.26% | 21,250 -1,500 | -7% | -$53.8K |
|
66
Duke Energy
DUK
$95.3B
| $693K | 0.24% | 8,932 | – | – |
|
67
MSC Industrial Direct
MSM
$5.02B
| $687K | 0.24% | 7,435 | – | – |
|
68
ResMed
RMD
$40.2B
| $682K | 0.23% | 10,990 +5,600 | +104% | +$348K |
|
69
Flowers Foods
FLO
$3.18B
| $672K | 0.23% | 33,651 | – | – |
|
70
Vertex Pharmaceuticals
VRTX
$100B
| $665K | 0.23% | 9,025 -600 | -6% | -$44.2K |
|
71
Edwards Lifesciences
EW
$47.8B
| $616K | 0.21% | +6,575 | New | +$616K |
|
72
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.4B
| $614K | 0.21% | 5,570 -350 | -6% | -$38.6K |
|
73
Bank of America
BAC
$376B
| $604K | 0.21% | 27,324 | – | – |
|
|
74
SPDR S&P Biotech ETF
XBI
$5.07B
| $592K | 0.2% | 9,995 -16,020 | -62% | -$949K |
|
75
Kinder Morgan
KMI
$60B
| $552K | 0.19% | 26,639 -3,928 | -13% | -$81.4K |
|